Epidemiology and Risks of Infections in Patients With Multiple Myeloma Managed With New Generation Therapies
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epidemiology and Risks of Infections in Patients With Multiple Myeloma Managed With New Generation Therapies
Authors
Keywords
Infection, Monoclonal antibody, Multiple myeloma, Risk, Second-generation therapy
Journal
Clinical Lymphoma Myeloma & Leukemia
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-02-22
DOI
10.1016/j.clml.2021.02.002
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
- (2019) J Peter Donnelly et al. CLINICAL INFECTIOUS DISEASES
- Risk factors for blood stream infections in multiple myeloma: A population-based study of 1154 patients in Denmark
- (2018) Rasmus Sørrig et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Risk factors for infections in newly diagnosed Multiple Myeloma patients: A Danish retrospective nationwide cohort study
- (2018) Rasmus Sørrig et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Risks, severity and timing of infections in patients with multiple myeloma: a longitudinal cohort study in the era of immunomodulatory drug therapy
- (2015) Benjamin W. Teh et al. BRITISH JOURNAL OF HAEMATOLOGY
- Infections in Hospitalised Patients with Multiple Myeloma: Main Characteristics and Risk Factors
- (2015) Toni Valkovic et al. Turkish Journal of Hematology
- Changing treatment paradigms for patients with plasma cell myeloma: Impact upon immune determinants of infection
- (2014) Benjamin W. Teh et al. BLOOD REVIEWS
- Invasive fungal infections in patients with multiple myeloma: a multi-center study in the era of novel myeloma therapies
- (2014) B. W. Teh et al. HAEMATOLOGICA
- Risks and burden of viral respiratory tract infections in patients with multiple myeloma in the era of immunomodulatory drugs and bortezomib: experience at an Australian Cancer Hospital
- (2014) Benjamin W. Teh et al. SUPPORTIVE CARE IN CANCER
- Incidence, risk factors, and implemented prophylaxis of varicella zoster virus infection, including complicated varicella zoster virus and herpes simplex virus infections, in lenalidomide-treated multiple myeloma patients
- (2013) C. König et al. ANNALS OF HEMATOLOGY
- New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)
- (2013) E M Ocio et al. LEUKEMIA
- Proteasome Inhibition Profoundly Affects Activated Human B Cells
- (2013) Arend Mulder et al. TRANSPLANTATION
- Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1
- (2011) S. V. Rajkumar et al. BLOOD
- Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Adverse Events
- (2011) S. Arastu-Kapur et al. CLINICAL CANCER RESEARCH
- Infectious complications in patients with multiple myeloma treated with new drug combinations containing thalidomide
- (2011) Massimo Offidani et al. LEUKEMIA & LYMPHOMA
- Infections in Patients with Multiple Myeloma in the Era of High‐Dose Therapy and Novel Agents
- (2009) Marcio Nucci et al. CLINICAL INFECTIOUS DISEASES
- The road to cure in multiple myeloma
- (2008) I. M. Ghobrial et al. BLOOD
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started